Preliminary development of a responder index for chronic low back pain

Journal of Rheumatology

Volumn 34, Issue 6, 2007, Pages 1386-1391

  Simon, Lee S ^a,f   Evans, Christopher ^b   Katz, Nathaniel ^c   Bombardier, Claire ^d   West, Christine ^e   Robbins, Jeffery ^e   Copley Merriman, Catherine ^e   Markman, J ^e   Coombs, John H ^e  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MAPI VALUES   (United States)

^c Analgesic Research   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e PFIZER INC   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Clinical responder criteria; Instruments; Low back pain; Outcome measures

Indexed keywords

CELECOXIB; PLACEBO; VALDECOXIB;

CHI SQUARE TEST; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; CONFERENCE PAPER; DAILY LIFE ACTIVITY; FUNCTIONAL ASSESSMENT; HEALTH STATUS; HUMAN; LOW BACK PAIN; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; RELIABILITY; STANDARD; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VALIDATION PROCESS; VALIDITY;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHRONIC DISEASE; CLINICAL TRIALS; FOCUS GROUPS; HEALTH STATUS INDICATORS; HUMANS; INTERNATIONAL COOPERATION; ISOXAZOLES; LOW BACK PAIN; OUTCOME ASSESSMENT (HEALTH CARE); PYRAZOLES; REPRODUCIBILITY OF RESULTS; SULFONAMIDES;

EID: 34250204551     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. van Tulder MW, Koes BW, Bouter LM. A cost-of-illness study of back pain in The Netherlands. Pain 1995;62:233-40.
2. Cassidy JD, Carroll LJ, Cote P. The Saskatchewan Health and Back Pain Survey. The prevalence of low back pain and related disability in Saskatchewan adults. Spine 1998;23:1860-6.
3. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003;81:646-56.
4. Deyo RA, Weinstein JN. Low back pain. N Engl J Med 2001;344:363-70.
5. World Health Organization. Low back pain initiative. Geneva: World Health Organization; 1999.
6. Andersson GB. Epidemiological features of chronic low-back pain. Lancet 1999;354:581-5.
7. Deyo RA, Rainville J, Kent DL. What can the history and physical examination tell us about low back pain? JAMA 1992;268:760-5.
8. Hart LG, Deyo RA, Cherkin DC. Physician office visits for low back pain. Frequency, clinical evaluation, and treatment patterns from a U.S. national survey. Spine 1995;20:11-9.
9. Croft PR, Macfarlane GJ, Papageorgiou AC, Thomas E, Silman AJ. Outcome of low back pain in general practice: a prospective study. BMJ 1998;316:1356-9.
10. Cedraschi C, Robert J, Goerg D, Perrin E, Fischer W, Vischer TL. Is chronic non-specific low back pain chronic? Definitions of a problem and problems of a definition. Br J Gen Pract 1999;49:358-62.
11. Ehrlich GE. Low back pain. Bull World Health Organ 2003;81:671-6.
12. van Tulder MW, Scholten RJ, Koes BW, Deyo RA. Nonsteroidal anti-inflammatory drugs for low back pain: a systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine 2000;25:2501-13.
13. Bombardier C, Hayden J, Beaton DE. Minimal clinically important difference. Low back pain: outcome measures. J Rheumatol 2001;28:431-8.
14. Garratt AM, Klaber MJ, Farrin AJ. Responsiveness of generic and specific measures of health outcome in low back pain. Spine 2001;26:71-7.
15. Yvanes-Thomas M, Calmels P, Bethoux F, et al. Validity of the French-language version of the Quebec Back Pain Disability Scale in low back pain patients in France. Joint Bone Spine 2002;69:397-405.
16. Coats TL, Borenstein DG, Nangia NK, Brown MT. Effects of valdecoxib in the treatment of chronic low back pain: results of a randomized, placebo-controlled trial. Clin Ther 2004;26:1249-60.
17. Rashiq S, Koller M, Haykowsky M, Jamieson K. The effect of opioid analgesia on exercise test performance in chronic low back pain. Pain 2003;106:119-25.
18. Deyo RA. Measuring the functional status of patients with low back pain. Arch Phys Med Rehabil 1988;69:1044-53.
19. Chronic low back pain. Waltham, MA: Decision Resources Inc., 2005.
20. Koes BW, Scholten RJ, Mens JM, Bouter LM. Efficacy of non-steroidal anti-inflammatory drugs for low back pain: a systematic review of randomised clinical trials. Ann Rheum Dis 1997;56:214-23.
21. Roland M, Morris R. A study of the natural history of back pain. Part 1: development of a reliable and sensitive measure of disability in low-back pain. Spine 1983;8:141-4.
22. Turk DC, Dworkin RH, Allen RR, et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 2003;106:337-45.
23. Anderson JJ, Baron G, van der Heijde D, Felson DT, Dougados M. Ankylosing Spondylitis Assessment Group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum 2001;44:1876-86.
24. Felson DT, Anderson JJ, Boers M, et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
25. Pham T, van der Heijde D, Altman RD, et al. OMERACT-OARSI Initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage 2004;12:389-99.
26. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9.
27. Deyo R, Battie M, Beurskens AJH, et al. Outcome measures for low back pain research: A proposal for standardized use. Spine 1998;23:2003-13.
28. Anderson JJ, Baron G, van der Heijde D, Felson DT, Dougados M. Ankylosing Spondylitis Assessment Group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum 2001;44:1876-86.